CALPOL a Well-Known Trademark: Delhi HC Bars WALPOL Use, Awards Rs 2 Lakh Damages to GSK Susmita Roy20 May 2026 5:15 PM ISTNew Delhi: The Delhi High Court has declared CALPOL, the widely used medicinal brand owned by GlaxoSmithKline Pharmaceuticals Limited, (GSK) as a...
Bristol Myers Squibb, China's Hengrui Sign USD 15.2 Billion Drug Collaboration Deal MD Bureau14 May 2026 8:14 PM ISTNew Delhi: Jiangsu Hengrui Pharmaceuticals, China's biggest drugmaker by market value, on Tuesday said it struck global collaboration and licensing...
GSK's Efimosfermin Secures USFDA Breakthrough, EMA PRIME Tags for MASH sheeba farhat28 April 2026 7:54 PM ISTLondon: GlaxoSmithKline plc (GSK) has announced that its investigational liver therapy efimosfermin has received both Breakthrough Therapy Designation...
GSK's Mo-rez Shows Strong Tumor Reduction Data, Tipped as Potential Blockbuster Cancer Drug sheeba farhat14 April 2026 8:07 PM ISTLondon: British drugmaker GSK's experimental targeted cancer drug Mo-rez has blockbuster potential, its head of oncology research has told...
FDA Approves First Drug for Cholestatic Pruritus in Primary Biliary Cholangitis Dr. Kamal Kant Kohli22 March 2026 8:45 PM ISTThe U.S. Food and Drug Administration has approved linerixibat, marking the first treatment specifically indicated for cholestatic pruritus in...
GSK Gets USFDA Nod for Liver Disease-Related Itching Drug Lynavoy sheeba farhat20 March 2026 11:26 PM ISTLondon: The U.S. Food and Drug Administration approved GSK's drug for severe relentless itching caused by a type of liver disease, the company said...
FDA Expands Approval of GSK's RSV Vaccine to At-Risk Adults Aged 18-49 Dr. Kamal Kant Kohli15 March 2026 8:45 PM ISTThe U.S. Food and Drug Administration has expanded the approved use of Arexvy, an RSV vaccine developed by GSK, to include adults aged 18 to 49 who...
USFDA Expands Use of GSK's RSV Vaccine Arexvy to Adults 18-49 at Risk sheeba farhat14 March 2026 10:30 AM ISTBengaluru: British drugmaker GSK said on Friday the U.S. Food and Drug Administration has expanded the approved age range for its respiratory...
GSK Licenses Linerixibat to Alfasigma in Deal Worth Up to USD 690 Million sheeba farhat10 March 2026 11:03 PM ISTBengaluru: GSK said on Monday it will receive up to USD 690 million from Italian pharmaceutical company Alfasigma for the worldwide rights to...
GSK Pharma Names Ronojit Biswas as New CFO, Juby Chandy Moves to APAC Role Parthika Patel4 March 2026 8:39 PM ISTNew Delhi: GlaxoSmithKline (GSK) Pharmaceuticals Limited has approved the appointment of Ronojit Biswas as Whole-Time Director and Chief Financial...
Alembic Bags USFDA Approval for USD 27 Million Lamotrigine ODT Market Parthika Patel26 Feb 2026 10:14 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug...
Sanofi Replaces CEO Paul Hudson Amid Vaccine Headwinds, Names Belen Garijo Successor sheeba farhat13 Feb 2026 2:00 PM ISTNew Delhi: French drugmaker Sanofi abruptly ousted its CEO Paul Hudson on Thursday, underscoring rising pressure from U.S. vaccine headwinds and a...
